Keywords: Osteoarthritis, Contrast Agent
Motivation: There is still a lack of noninvasive technique in quantifying the acidic extracellular pH of damaged cartilage in early osteoarthritis (OA).
Goal(s): We aimed to fabricate an advance reactive oxygen species (ROS) responsive CEST-MRI contrast agent for damaged cartilaged imaging and treatment in OA.
Approach: We use CEST-MRI to investigate whether our sythesized PLGE-TK-PEG@PDA-SA nanoparticles repond to ROS accumulating in damaged cartilage could result in the exsistance of CEST signal, while no CEST signal would be tested in normal cartilage without excessive ROS.
Results: The PLGA-TK-PEG@PDA-SA nanoparticles could effectively respond to ROS and then produce significant CEST effect for precisely pH measurement.
Impact: The novel PLGA-TK-PEG@PDA-SA CEST- MRI contrast could be used to noninvasively monitor the extracellular pH of cartilage in osteoarthritis, and eliminate excessive ROS to defend against its damage to cartilage. This smart, sensitive ROS-responsive nanoprobe is promising for OA theranostics.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords